Dysport® Adult Upper Limb Spasticity Extension Study

• Status: Completed
• Trial end date: 0000-00-00
• Target enrollment: 258
• Participant gender: Both

Summary

The purpose of this research study is to assess the long term safety of Dysport in hemiparetic subjects with upper limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ipsen
• Treatments: abobotulinumtoxinA; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA
• Last Updated: 2015-05-07

Criteria

Inclusion Criteria:

• Completion of the double blind study, Y-52-52120-145

Exclusion Criteria:

• Major limitation in the passive range of motion in upper limb